BioCity Biopharma Unveils Positive Late-Breaking Results from 2-SUCCEED Trial of SC0062 for IgA Nephropathy at ASN Kidney Week 2024

BioCity Biopharma (BioCity) announced late-breaking results of the 2-SUCCEED clinical trial of SC0062, a selective endothelin receptor type A (ETA) an...

November 05, 2024 | Tuesday | News
Abzena Expands Quality Control Testing Capabilities at San Diego Facility, Elevating Biologics Manufacturing and Microbiology Standards

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates announced a significant expansion in their quality control (QC) test...

October 31, 2024 | Thursday | News
Eli Lilly Reports Positive Phase 3b Results for Donanemab, Reducing Amyloid-Related Edema in Alzheimer's Patients

Eli Lilly and Company (NYSE: LLY) announced positive results from the TRAILBLAZER-ALZ 6 Phase 3b study, showing a reduction in amyloid-related imaging...

October 30, 2024 | Wednesday | News
Positive Phase 3 Results for Dupixent in Chronic Spontaneous Urticaria to be Unveiled at ACAAI 2024

Positive data from the phase 3 LIBERTY-CUPID Study C evaluating the investigational use of Dupixent (dupilumab) in biologic-naive patients with uncontrolle...

October 25, 2024 | Friday | News
Agilent Technologies Introduces Next-Generation InfinityLab LC Series with Innovative Assist Technology, Transforming Lab Automation and Efficiency

Agilent Technologies Inc. (NYSE: A) announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infi...

October 22, 2024 | Tuesday | News
Foresee Pharmaceuticals Completes Phase 1 Trial of Linvemastat, a Promising Oral MMP-12 Inhibitor for Respiratory and IBD Conditions

Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced the successful completion of its Phase 1 single and multiple ascending dose (SAD/MAD) clinical ...

October 21, 2024 | Monday | News
BOTOX® Cosmetic Gains FDA Approval for Treatment of Platysma Bands, Expanding Aesthetic Options Beyond the Face

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of BOTOX® Cosmetic for temporary improvement in the appearanc...

October 21, 2024 | Monday | News
Eli Lilly's Mirikizumab Shows Promising Histologic Response in Phase 3 Study for Crohn's Disease, Outperforming Ustekinumab

Eli Lilly and Company (NYSE: LLY) announced data demonstrating more patients with moderately to severely active Crohn's disease treated with miri...

October 15, 2024 | Tuesday | News
Merck Opens €290 Million State-of-the-Art Biosafety Testing Facility in Maryland, Accelerating Global Drug Development

Note: Merck operates as MilliporeSigma in North America.   Facility consolidates biosafety testing, analytical development, and cell bank manufact...

October 10, 2024 | Thursday | News
QIAGEN Launches PAXgene Urine Liquid Biopsy Set, Advancing Non-Invasive cfDNA Collection and Stabilization

PAXgene Urine Liquid Biopsy Set with collection cup and a nucleic acid stabilizing tube enables non-invasive sample collection and direct cell-free DNA sta...

September 26, 2024 | Thursday | News
Roche Launches cobas® Respiratory flex Test, Powered by Innovative TAGS Technology

New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a single patient sample on t...

September 24, 2024 | Tuesday | News
Thermo Fisher's PPD Clinical Research Expands to GoCo Health Innovation City in Sweden

The PPD clinical research business joins GoCo Health Innovation City in Gothenburg, Sweden The PPD™ clinical research business of Thermo Fisher Sc...

September 19, 2024 | Thursday | News
FDA Issues Warning Letters to Two Chinese Testing Labs Over Data Integrity and Animal Care Violations

Firms Provided Third-Party, Nonclinical Premarket Testing; Agency Review Ongoing U.S. Food and Drug Administration issued warni...

September 12, 2024 | Thursday | News
Roche Expands Digital Pathology Platform with Over 20 AI Algorithms to Enhance Cancer Research and Precision Medicine

The Roche Digital Pathology Open Environment brings together a wide array of innovative AI-based pathology tools to help clinicians...

September 09, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close